PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,279,384 | -11.9% | 2,437,742 | +21.7% | 0.00% | 0.0% |
| Q2 2023 | $28,677,691 | +146.0% | 2,002,632 | +22.6% | 0.00% | – |
| Q1 2023 | $11,658,979 | -38.7% | 1,632,910 | -3.6% | 0.00% | -100.0% |
| Q4 2022 | $19,011,516 | +11.2% | 1,694,431 | +9.8% | 0.00% | 0.0% |
| Q3 2022 | $17,098,000 | +28.4% | 1,543,150 | -2.2% | 0.00% | – |
| Q2 2022 | $13,318,000 | -29.0% | 1,577,737 | +14.5% | 0.00% | -100.0% |
| Q1 2022 | $18,761,000 | -35.2% | 1,378,517 | -6.4% | 0.00% | 0.0% |
| Q4 2021 | $28,974,000 | -23.7% | 1,473,125 | +24.5% | 0.00% | 0.0% |
| Q3 2021 | $37,970,000 | -3.3% | 1,182,878 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $39,282,000 | +28.2% | 1,160,437 | +42.2% | 0.00% | 0.0% |
| Q1 2021 | $30,647,000 | +16.6% | 815,940 | +3.2% | 0.00% | 0.0% |
| Q4 2020 | $26,273,000 | -0.1% | 790,880 | +10.3% | 0.00% | 0.0% |
| Q3 2020 | $26,289,000 | +10.0% | 716,912 | -1.2% | 0.00% | 0.0% |
| Q2 2020 | $23,890,000 | +58.2% | 725,927 | +24.1% | 0.00% | 0.0% |
| Q1 2020 | $15,104,000 | -24.3% | 584,946 | -8.7% | 0.00% | 0.0% |
| Q4 2019 | $19,952,000 | – | 640,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |